Allogeneic Hematopoietic Cell Transplantation for Chronic Myelomonocytic Leukemia: Relapse-Free Survival Is Determined by Karyotype and Comorbidities-Reference-Cited by-同舟云学术

Allogeneic Hematopoietic Cell Transplantation for Chronic Myelomonocytic Leukemia: Relapse-Free Survival Is Determined by Karyotype and Comorbidities

Published:2011-06 Issue:6 Volume:17 Page:908-915
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Eissa Hesham,Gooley Ted A.,Sorror Mohamed L.,Nguyen Franchesca,Scott Bart L.,Doney Kristine,Loeb Keith R.,Martin Paul J.,Pagel John M.,Radich Jerry P.,Sandmaier Brenda M.,Warren E. Houston,Storb Rainer,Appelbaum Frederick R.,Deeg H. Joachim

Funder

National Institutes of Health

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference29 articles.

1. Prognostic factors and scoring systems in chronic myelomonocytic leukemia: a retrospective analysis of 213 patients;Onida;Blood,2002

2. Chronic myelomonocytic leukemia in the light of the WHO proposals;Germing;Haematologica,2007

3. International scoring system for evaluating prognosis in myelodysplastic syndromes;Greenberg;Blood,1997

4. JAK2V617F activating mutation is associated with the myeloproliferative type of chronic myelomonocytic leukaemia;Pich;J Clin Pathol,2009

5. JAK2 mutation 1849G>T is rare in acute leukemias but can be found in CMML, Philadelphia chromosome-negative CML, and megakaryocytic leukemia;Jelinek;Blood,2005

Cited by 112 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhanced Survival of Chronic Myelomonocytic Leukemia-Dysplastic over Proliferative Subtype after Allogeneic Hematopoietic Cell Transplant: A Tertiary Center Experience and Literature Review;Acta Haematologica;2024-06-26

2. Management of adult patients with CMML undergoing allo-HCT: recommendations from the EBMT PH&G Committee;Blood;2024-05-30

3. Chronic myelomonocytic leukemia: 2024 update on diagnosis, risk stratification and management;American Journal of Hematology;2024-03-07

4. Updated comparable efficacy of cord blood transplantation for chronic myelomonocytic leukaemia: a nationwide study;Bone Marrow Transplantation;2024-02-08

5. EASIX and CPSS Cytogenetics score-based composite risk model for patients with CMML undergoing allogeneic transplant;Bone Marrow Transplantation;2024-01-13